Definitive Contract 75N91021C00022
Award Date 9/9/21
Potential Completion Date 9/15/22
Potential Value $399K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98122, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This definitive firm fixed price contract for $246,378 was awarded by the National Institutes of Health National Cancer Institute to Biodepot LLC, a small disadvantaged, woman-owned business. It responds to Topic 407 of the SBIR Phase I solicitation seeking proposals for cloud-based software to support the Cancer Research Data Commons. Placed of performance will be in Seattle, Washington. The SBIR program aims to stimulate technological innovation to meet federal research needs through awards to...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (NCI) to Inlighta Biosciences L.L.C., a woman-owned small business. The $298,230.00 firm fixed-price contract is for a Phase I Small Business Innovation Research (SBIR) project titled "Non-Invasive Subtyping of Aggressive Tumor and Its Environment" as part of the NCI Cancer Moonshot initiative. The original solicitation was issued under the NIH/CDC...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Infotech Soft, Inc., a woman-owned small business. The contract, valued at $223,808.00, is for the development of a "Platform for High-Throughput Analysis of Integrated Cancer Imaging and Multi-Omics Data" under SBIR Topic #364. The contract is a Definitive Contract with a Firm Fixed Price...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- <p>The U.S. Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I firm-fixed-price contract to Mediomics LLC, a woman-owned small business, to develop novel tools for site-specific quantitative analysis of RNA modifications. The contract has a potential value of $248,357.00 and a completion date of June 18, 2018.</p>
- This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $386,526 firm fixed price definitive contract to Biodata Consortium, LLC under Topic #411 of the National Institutes of Health and Centers for Disease Control and Prevention SBIR solicitation. Biodata Consortium will provide de-identification software tools to support cancer imaging research, as requested in the solicitation. The contract is set aside for total small business and will be...
- <p>This is a small business set-aside contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Tatva Biosciences LLC, a woman-owned small business. The $224,869.00 firm-fixed-price contract is for the establishment of cancer cell lines to support research into health disparities in ovarian cancer. The contract was awarded on September 19, 2016 and has an ultimate completion date of August 18, 2017.</p>
This definitive contract from the Department of Health and Human Services' National Institutes of Health National Cancer Institute, with a potential value of $398,815, was awarded to Biodepot LLC, a self-certified small disadvantaged, woman-owned, and for-profit business, to address Topic 418 under the agency's Small Business Innovation Research Program. Specifically, Biodepot will conduct research on "HIGH THROUGHPUT SPATIALOMICS PROFILING FOR THICK TUMOR TISSUES," which involves developing techniques for high-resolution spatial analysis of gene expression and molecular markers within thick tumor samples. The contract has a period of performance through September 15, 2022.
Generated 2/15/24, 10:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $0 | 6/1/22 | |
| P00001 | Other Administrative Action | $0 | 11/5/21 | |
| Not listed | Not listed | $398.8k | 9/9/21 |